A client who suspects she is pregnant tells the nurse she has a peptic ulcer that is being treated with misoprostol, a synthetic prostaglandin E drug.
How should the nurse respond?

Choice A rationale

While bulb syringe use is important for clearing the newborn's airways, it is not the immediate priority during the fourth stage of labor. This information can be provided later during routine newborn care education.

Choice B rationale

Newborn screening tests are important for identifying potential health issues, but the fourth stage of labor is focused on stabilizing the mother and infant and initiating breastfeeding. Screening information can be shared during the postpartum period.

Choice C rationale

Techniques to breastfeed are critical information to provide during the fourth stage of labor as it helps establish successful breastfeeding early on. This support can enhance maternal-infant bonding and promote breastfeeding success.

Choice D rationale

Circumcision care is relevant for parents who choose to circumcise their infant, but it is not the immediate priority during the fourth stage of labor. This information can be provided during subsequent postpartum visits.

Choice A rationale

Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that can induce uterine contractions, increasing the risk of a spontaneous miscarriage, particularly in early pregnancy.

Choice B rationale

Misoprostol is not known to increase the risk of preeclampsia. Preeclampsia involves high blood pressure and potential damage to other organ systems, typically appearing after 20 weeks of pregnancy.

Choice C rationale

Misoprostol does have an effect on the unborn child due to its ability to cause uterine contractions and cervical ripening, potentially leading to miscarriage.

Choice D rationale

Misoprostol is not associated with an increased risk of postpartum hemorrhaging after delivery. It is often used to manage postpartum hemorrhage by promoting uterine contractions.